Gilead Sciences
GILD
Real-time BATS EXCHANGE - 09/24 09:59:44 pm
75.635USD
+0.17%
Prev.75.5100
Open75.2600
High76.2100
Low75.2400
Volume9 578 716
Financials
Sales 2018 21 377 M
EBIT 2018 11 220 M
R. net 2018 6 650 M
Debt 2018 12 363 M
Rend. 2018 3,01%
P/E ratio 2018 14,98
P/E ratio 2019 13,78
EV / Sales 2018 5,16x
EV / Sales 2019 5,12x
Capitalization 97 887 M
Company
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need.The firm offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey,...
Sector :
Bio Therapeutic Drugs
Calendar :
2018-09-27 Presentation
Trading Rating :
Investor Rating :
Latest news
09:56pGILEAD SCIENCES : to Slice List Prices of Liver Drugs
DJ
03:19pGILEAD SCIENCES : Subsidiary to Launch Authorized Generics to Treat HCV
PU
02:33pGILEAD SCIENCES : Subsidiary to Launch Authorized Generics of EpclusaŽ (Sofosbuvir/Velpatasvir) and HarvoniŽ (Ledipasvir/Sofosbuvir) for the Treatment of Chronic Hepatitis C
BU
09/20GILEAD SCIENCES' : Trademark Application for "WILKARTI" Filed
AQ
09/20GILEAD SCIENCES : Trademark Application for "CAARTUVY" Filed by Gilead Sciences
AQ
09/20GILEAD SCIENCES' : Trademark Application for "TUCAARTI" Filed
AQ
09/20GILEAD SCIENCES : Researchers Submit Patent Application, "Inhibitors Of Bruton'S Tyrosine Kinase", for Approval (USPTO 20180251464)
AQ
09/20GILEAD SCIENCES : An Application for the Trademark "WILKARTA" Has Been Filed by Gilead Sciences
AQ
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralBullishNeutral
Resistance77,378,985,5
Spread/Res.-2,1%-4,0%-11%
Spread/Supp.5,2%5,2%16%
Support72,072,065,4